Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Covid-19 crawled time : 09:00 save search
Analysis of COVID-19|Athleisure Market Records a CAGR of over 7% by 2025| adidas AG, ALALA, ALO LLC, American Eagle Outfitters Inc., Carbon38 Inc. and more among the key players in the market
Published: 2023-10-25 (Crawled : 09:00) - prnewswire.com
DKILF | $126.0 -0.4% 25.48% 640
|
Producer Manufacturing
|
| O: 0.18%
H: 5.1%
C: 0.0%
DKILY | $12.49 -3.33% -0.07% 340K
|
Manufacturing
|
| O: 4.35%
H: 0.0%
C: -3.03%
LULU | $344.86 1.74% 1.66% 1.9M
|
Retail Trade
|
| O: -0.59%
H: 0.7%
C: -1.07%
covid-19 market
CHMP Adopts Positive Opinion to Extend the Use of Veklury® (Remdesivir) to Treat COVID-19 in People With Severe Renal Impairment, Including Those on Dialysis
Published: 2023-05-26 (Crawled : 09:00) - biospace.com/
GILD | $66.93 -0.57% -0.55% 3.8M
|
Health Technology
|
| O: 0.45%
H: 0.79%
C: -1.17%
covid-19 veklury chmp renal positive dialysis
New Finaccord study reveals dramatic changes in consumer attitudes to travel insurance since COVID-19
Published: 2022-12-16 (Crawled : 09:00) - prnewswire.com
AON | $304.79 0.24% 0.0% 830K
|
Finance
|
| O: -0.87%
H: 0.0%
C: -0.75%
covid-19 travel insurance study
Ministry of Health, Labour and Welfare in Japan Approves Partial Change to a New Drug Authorization for Moderna's Omicron-Targeting Bivalent Booster COVID-19 Vaccine, mRNA-1273.222
Published: 2022-11-01 (Crawled : 09:00) - biospace.com/
MRNA | News S | $103.44 -0.34% -0.33% 1.5M
|
Health Technology
|
| O: 2.95%
H: 2.66%
C: -0.1%
covid-19 drug japan change authorization
Clover’s COVID-19 Vaccine Candidate Receives European Union GMP Certificate
Published: 2022-09-20 (Crawled : 09:00) - globenewswire.com
DVAX | $11.43 -0.52% -0.44% 2.5M
|
Health Technology
|
| O: -1.69%
H: 3.4%
C: -0.77%
covid-19 candidate vaccine
The Maltese Islands Reopen for Summer, COVID-19 Restrictions Removed
Published: 2022-06-14 (Crawled : 09:00) - prnewswire.com
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: -2.13%
H: 1.45%
C: -1.45%
covid-19 covid
Takeda and Moderna Announce Plans to Transfer Marketing Authorization for Spikevax™ COVID-19 Vaccine in Japan to Moderna
Published: 2022-05-31 (Crawled : 09:00) - biospace.com/
TAK | $13.15 -0.61% 0.0% 1.5M
|
Health Technology
|
| O: -2.24%
H: 0.35%
C: -0.14%
MRNA | News S | $103.44 -0.34% -0.33% 1.5M
|
Health Technology
|
| O: 5.09%
H: 0.0%
C: 0.0%
covid-19 japan vaccine authorization
Moderna and Takeda Announce Plans to Transfer Marketing Authorization for Spikevax(TM) COVID-19 Vaccine in Japan to Moderna
Published: 2022-05-31 (Crawled : 09:00) - biospace.com/
TAK | $13.15 -0.61% 0.0% 1.5M
|
Health Technology
|
| O: -2.24%
H: 0.35%
C: -0.14%
MRNA | News S | $103.44 -0.34% -0.33% 1.5M
|
Health Technology
|
| O: 5.09%
H: 0.0%
C: 0.0%
covid-19 japan vaccine authorization
Bavarian Nordic Reports Omicron Data from Phase 2 Trial of its COVID-19 Booster Vaccine Candidate
Published: 2022-05-05 (Crawled : 09:00) - globenewswire.com
JNJ | News | $144.77 0.22% 0.22% 7.9M
|
Health Technology
|
| O: 0.72%
H: 0.0%
C: 0.0%
covid-19 vaccine trial phase 2
Ascletis Announces 3CLpro Inhibitor ASC11 Demonstrated Potential to be Effective Treatment for COVID-19
Published: 2022-04-19 (Crawled : 09:00) - prnewswire.com
ENTA | News | $14.0 -8.85% -9.68% 190K
|
Health Technology
|
| O: -5.24%
H: 3.73%
C: 2.73%
asc11 covid-19 treatment potential
COVID-19 PTSD: What You Need to Know
Published: 2022-03-21 (Crawled : 09:00) - brainsway.com
BWAY | News | $5.05 -1.17% -0.99% 17K
|
Health Technology
|
| O: -3.48%
H: 7.99%
C: 3.61%
covid-19 covid
Valneva Receives Initial CHMP Assessment of its Inactivated, Adjuvanted COVID-19 Vaccine Candidate VLA2001
Published: 2022-02-25 (Crawled : 09:00) - biospace.com/
DVAX | $11.43 -0.52% -0.44% 2.5M
|
Health Technology
|
| O: 11.25%
H: 0.0%
C: 0.0%
covid-19 valneva covid vla200 chmp vaccine vla2001
Relief Reports that its U.S. Collaboration Partner has Announced that the U.S. National Institutes of Health Study of Aviptadil in Critical COVID-19 is Cleared to Complete Full Enrollment
Published: 2022-02-16 (Crawled : 09:00) - biospace.com/
RLFTF | $1.4 3.7% 11.45% 1.3K
|
n/a
|
| O: -7.15%
H: 7.7%
C: 6.89%
covid-19 aviptadil health covid report collaboration enroll
Evotec Receives € 7.5 m Grant for Development of COVID-19 Therapeutic
Published: 2022-01-03 (Crawled : 09:00) - biospace.com/
EVO | News | $7.24 3.28% 1.27% 55K
|
Manufacturing
|
| O: -0.51%
H: 0.0%
C: -0.72%
covid-19 covid granted grant
Valneva Announces Positive Homologous Booster Data for Inactivated, Adjuvanted COVID-19 Vaccine Candidate VLA2001
Published: 2021-12-16 (Crawled : 09:00) - biospace.com/
DVAX | $11.43 -0.52% -0.44% 2.5M
|
Health Technology
|
| O: 5.3%
H: 3.56%
C: -1.05%
covid-19 valneva covid vla200 positive vaccine vla2001
Relief Reports that U.S. Collaboration Partner Announces New, Favorable Safety Report for Aviptadil in NIH Sponsored ACTIV-3b Critical Care Study in Patients with Life-Threatening COVID-19
Published: 2021-12-15 (Crawled : 09:00) - biospace.com/
NRXP | News 0 d | $4.18 -2.79% -3.12% 91K
|
Manufacturing
|
| O: -0.53%
H: 1.78%
C: -3.2%
covid-19 aviptadil covid collaboration pons
Top DevOps Services and Popular Tools at GoodFirms Assist Businesses in Faster Software Development Cycle During Covid-19
Published: 2021-12-14 (Crawled : 09:00) - prnewswire.com
FNCTF | News | $11.0354 -0.83% -20.84% 34K
|
Communications
|
| O: 1.65%
H: 0.0%
C: -1.39%
covid-19 covid software
Mainz Biomed Launches Ecommerce Store for ColoAlert to Assist Patient Access during Covid-19 Pandemic
Published: 2021-12-07 (Crawled : 09:00) - globenewswire.com
MYNZ | $0.9312 -2.33% 2.02% 22K
|
|
| O: -2.11%
H: 2.84%
C: 1.23%
covid store covid-19
Post COVID-19 Coffee Bean Market Procurement Research Report | SpendEdge
Published: 2021-10-01 (Crawled : 09:00) - prnewswire.com
DD | News | $73.09 0.72% -0.81% 2.2M
|
Process Industries
|
| O: 0.34%
H: 0.0%
C: 0.0%
covid research covid-19
FDA has declined Humanigen’s Emergency Use Authorization (EUA) Request for Lenzilumab in Hospitalized COVID-19 Patients
Published: 2021-09-09 (Crawled : 09:00) - biospace.com/
HGEN | $0.0361 -61.5% 120M
|
Health Technology
|
| O: -59.56%
H: 35.35%
C: 30.44%
covid fda lenzilumab merge authorized covid-19 emergency use authorization
Gainers vs Losers
| 57% | 43% |
Top 10 Gainers
INVO | $1.82 139.47% 56.82% 220M
|
Health Technology
SINT | $0.0373 62.88% 37.26% 460M
|
Health Technology
WISA 4 | $9.25 51.64% 34.27% 64M
|
Electronic Technology
EDBL | News | $6.66 46.37% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 600K
|
Manufacturing
TCON | $2.29 33.92% 26.61% 1.8M
|
Health Technology
TIRX | $0.4848 7.49% 24.58% 5.9M
|
SRFM 4 | $0.3859 -12.3% 23.84% 660K
|
n/a
CTM | $0.2201 -2.31% 22.67% 48K
|
n/a
VNDA | News | $5.24 29.38% 22.56% 24M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.